# 3995
CIDRAP News tonight has two in-depth feature articles, and eight news briefs.
First Lisa Schnirring takes a look at an HHS tabletop vaccine exercise held in Minneapolis, moderated once again by Forrest Sawyer, and this time focusing on problems related to the vaccine rollout.
Officials take a heartland look at pandemic vaccine messages
Lisa Schnirring
Staff Writer
Nov 11, 2009 (CIDRAP News) – In an effort to gauge how pandemic vaccine messages are being received outside the Washington, DC, beltway, the US Department of Health and Human Services (HHS) yesterday held a tabletop exercise in Minneapolis and included participants from local media outlets and public health departments.
The tabletop exercise was the HHS's third one to cover pandemic vaccine communications. The last was held on Oct 2 in New York City before states received their first vaccine doses, so yesterday's scenario was unusual because it touched on problems and events related to the actual vaccine rollout.
News Editor Robert Roos then covers an announcement from Sanofi Pasteur where they say they’ve improved vaccine yield and expect to deliver 75 million doses of vaccine by the end of the year.
Sanofi vows to finish making H1N1 vaccine by year's end
Robert Roos
Nov 11, 2009 (CIDRAP News) – After a slow start in producing H1N1 flu vaccine, Sanofi Pasteur has improved yields threefold and expects to fulfill its government order for 75 million doses by the end of the year, company officials said today.
"We promised to provide 75 million doses by the end of the year, and we'll do exactly what we said we were going to do," Christopher Viehbacher, chief executive officer (CEO) of Sanofi-Aventis, Sanofi Pasteur's corporate parent, told reporters at a briefing that was streamed over the Web today.
H1N1 Flu Breaking News
FDA approves Glaxo's H1N1 vaccine
FDA head advocates for pandemic vaccine
Father of sick boy develops oseltamivir-resistant H1N1
Online tool helps locate flu shots
Canada's plan to vaccinate Afghan detainees draws fire
Pandemic deaths doubling weekly in Europe
And a reminder, among the many resources available on the CIDRAP site is this overview of H1N1, which is both authoritative and up-to-date. I refer to it, and many of the other references on the site, often.
Novel H1N1 Influenza (Swine Flu)
Last updated November 6, 2009
Agent
Swine Influenza in Pigs
Swine-Origin Influenza in Humans: Historic Perspective
2009 Pandemic: Case Counts and Clinical Features
Pandemic Perspective
Laboratory Testing for the Novel H1N1 Virus in Humans
Community Mitigation Measures
Recommendations for Use of Influenza A H1N1 2009 Monovalent Vaccine
Vaccine Development
Use of Antiviral Agents
Infection Control Considerations
Food Safety Issues
References
You’ll find similar overviews for avian flu on CIDRAP at these links.
Avian Influenza (Bird Flu): Agricultural and Wildlife Considerations
